CN106036815A - Nutritional support composition for rehabilitation of postoperative patient - Google Patents
Nutritional support composition for rehabilitation of postoperative patient Download PDFInfo
- Publication number
- CN106036815A CN106036815A CN201610098501.7A CN201610098501A CN106036815A CN 106036815 A CN106036815 A CN 106036815A CN 201610098501 A CN201610098501 A CN 201610098501A CN 106036815 A CN106036815 A CN 106036815A
- Authority
- CN
- China
- Prior art keywords
- weight
- nutritional support
- support compositions
- compositions
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000002980 postoperative effect Effects 0.000 title abstract description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 12
- 244000068988 Glycine max Species 0.000 claims abstract description 11
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 11
- 229920001202 Inulin Polymers 0.000 claims abstract description 11
- 229920001491 Lentinan Polymers 0.000 claims abstract description 11
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 11
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 11
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 11
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 11
- 229940029339 inulin Drugs 0.000 claims abstract description 11
- 229940115286 lentinan Drugs 0.000 claims abstract description 11
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 11
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 9
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 9
- 239000004376 Sucralose Substances 0.000 claims abstract description 9
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 9
- 239000001168 astaxanthin Substances 0.000 claims abstract description 9
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 9
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 9
- 235000012661 lycopene Nutrition 0.000 claims abstract description 9
- 229960004999 lycopene Drugs 0.000 claims abstract description 9
- 239000001751 lycopene Substances 0.000 claims abstract description 9
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 9
- 235000019408 sucralose Nutrition 0.000 claims abstract description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 9
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 7
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 7
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract 2
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract 2
- 241000018646 Pinus brutia Species 0.000 claims abstract 2
- 235000012054 meals Nutrition 0.000 claims description 15
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 240000006240 Linum usitatissimum Species 0.000 claims description 9
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 9
- 235000004426 flaxseed Nutrition 0.000 claims description 9
- 241000209140 Triticum Species 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 230000000378 dietary effect Effects 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 abstract description 12
- 108010073771 Soybean Proteins Proteins 0.000 abstract description 10
- 235000019710 soybean protein Nutrition 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 7
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 10
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 description 7
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- -1 oligofructose Polymers 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- QNTKVQQLMHZOKP-NEJDVEAASA-N (2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]- Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QNTKVQQLMHZOKP-NEJDVEAASA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 235000011609 Pinus massoniana Nutrition 0.000 description 2
- 241000018650 Pinus massoniana Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000011610 Pinus tabuliformis Nutrition 0.000 description 1
- 241000018651 Pinus tabuliformis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- QNTKVQQLMHZOKP-UHFFFAOYSA-N fructofuranosylnystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OCC3(OC4C(C(O)C(O)C(CO)O4)O)C(C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 QNTKVQQLMHZOKP-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a nutritional support composition for rehabilitation of a postoperative patient. The composition comprises lactalbumin, soybean protein isolate, soybean peptide, flaxseed powder, oat dietary fiber, maltodextrin, fructo-oligosaccharide, inulin, pine pollen, astaxanthin and/or lycopene, lentinan and sucralose. The energy supply ratio of the nutritional support composition accords with standards advocated by Chinese Society of Nutrition; and the nutritional support composition is healthy and reasonable and can substantially the immunity of a user.
Description
Technical field
The present invention relates to field of nutrition, be specifically related to a kind of for nutritional support during postoperative patient rehabilitation and combinations thereof
Thing, this nutritional support compositions includes following component: lactalbumin, soybean protein isolate, soybean polypeptide, linseed meal, Herba bromi japonici
Dietary fiber, maltodextrin, oligofructose, inulin, Pollen Pini, compounding fiber element, composite mineral matter, astaxanthin and/or kind
Lycopene, lentinan, wheat essence and sucralose.The energy supply ratio of described nutritional support compositions meets Chinese Soclety of Nutrition
Standard, healthy rationally, the immunity of user can also be significantly improved simultaneously.
Background technology
Due to the becoming more meticulous of people's dietary structure in the modern life, quantity of motion reduces, and causes many in crowd individual occur
The imbalance of the nutrition such as heat exceeds standard, dietary fiber Deficiency of Intake, trace element deficiency.Therefore Chinese Soclety of Nutrition's recommended dietary
Meet certain energy supply ratio.Especially for ill patient, it more needs comprehensive nutrition, and some patient is not suitable for
Fed regular diet, hence it is highly desirable to a kind of balanced in nutrition, it is prone to the nutritional support compositions taken simultaneously.
Summary of the invention
It is an object of the invention to provide a kind of balanced in nutrition, be prone to the nutritional support compositions taken simultaneously.And, send out
A person of good sense finds under study for action, compared with the alimentation composition of the present invention is individually taken with each component, it is possible to significantly increases and takes
The immunity of person.
In one embodiment, the nutritional support compositions of the present invention includes following component: the milk surum of 10-20 weight %
Albumen, the soybean protein isolate of 5-20 weight %, the soybean polypeptide of 0.1-5 weight %, the linseed meal of 10-30 weight %, 10-
The Herba bromi japonici dietary fiber of 30 weight %, the maltodextrin of 20-40 weight %, the oligofructose of 0.1-5 weight %, 0.1-10 weight
The amount inulin of %, the Pollen Pini of 0.1-10 weight %, the astaxanthin of 0.01-1 weight % and/or lycopene and 0.01-1 weight
The lentinan of amount %.
Preferably, the nutritional support compositions of the present invention also includes: the compound cellulose of 0.01-1 weight % and 0.01-3
The composite mineral matter of weight %.
It is highly preferred that the nutritional support compositions of the present invention also includes: the wheat essence of 0.01-1 weight % and 0.001-
The sucralose of 0.5 weight %.
In another embodiment, the nutritional support compositions of the present invention includes following component: the breast of 12-18 weight %
Albumin, the soybean protein isolate of 8-15 weight %, the soybean polypeptide of 1-4 weight %, the linseed meal of 15-25 weight %, 15-
The Herba bromi japonici dietary fiber of 25 weight %, the maltodextrin of 22-38 weight %, the oligofructose of 1-4 weight %, 2-8 weight %
Inulin, the Pollen Pini of 0.5-5 weight %, the astaxanthin of 0.1-0.8 weight % and/or lycopene and 0.1-0.8 weight %
Lentinan.
Preferably, the nutritional support compositions of the present invention also includes: the compound vitamin of 0.02-0.8 weight % and 0.02-
The composite mineral matter of 2 weight %.
It is highly preferred that the nutritional support compositions of the present invention also includes: the wheat essence of 0.1-1 weight % and 0.005-
The sucralose of 0.1 weight %.
In still another embodiment, the nutritional support compositions of the present invention includes following component: the breast of 13-17 weight %
Albumin, the soybean protein isolate of 10-14 weight %, the soybean polypeptide of 1.5-3 weight %, the linseed meal of 16-20 weight %,
The Herba bromi japonici dietary fiber of 16-20 weight %, the maltodextrin of 24-32 weight %, the oligofructose of 1.5-3 weight %, 3-7 weight
The amount inulin of %, the Pollen Pini of 0.8-2 weight %, the astaxanthin of 0.2-0.7 weight % and/or lycopene, 0.2-0.7 weight
Amount % lentinan,.
Preferably, the nutritional support compositions of the present invention also includes: the compound vitamin of 0.1-0.7 weight % and 0.5-
The composite mineral matter of 1.8 weight %.
It is highly preferred that the nutritional support compositions of the present invention also includes: the wheat essence of 0.2-0.8 weight % and 0.01-
The sucralose of 0.08 weight %.
On the other hand, the present invention provides a kind of nutritional support meal replacement powder, and it is added by the nutritional support compositions of the present invention
Work forms.Described processing refers to powder process.
It yet still another aspect, the invention still further relates to the nutritional support compositions of the present invention and nutritional support meal replacement powder for nutrition
The purposes supported.
Detailed description of the invention
Component in the nutritional support compositions of the present invention is described below respectively:
Lactalbumin is a kind of protein extracted from milk, is referred to as the king of albumen, has and is of high nutritive value, easily disappears
Change and absorb, containing the features such as various active composition, one of human body high quality protein supplement being well recognized as.
Soybean protein isolate is a kind of full price protide food additive with low temperature desolventizing soybean meal as raw material production.Greatly
In bean separation albumen, protein content is more than 90%, and amino acid classes has nearly 20 kinds, and containing essential amino acid.
The soybean polypeptide i.e. abbreviation of " peptidyl soybean protein hydrolyate ", be soybean protein through protease effect, then through spy
The protein hydrolysate very processed and obtain.The essential amino acids composition of soybean polypeptide is just the same with soybean protein, contains
Amount is abundant and balances, and polypeptide compound is easily digested.
Linseed meal is by Semen Lini grind into powder and then edible a kind of edible powder.
Herba bromi japonici dietary fiber is the insoluble dietary fiber from Herba bromi japonici.Dietary fiber is a kind of polysaccharide, and it can not
Absorbed by pipe intestinal digesting, energy can not be produced.
Maltodextrin refers to starch as raw material, is referred to as maltodextrin through controlling hydrolysis DE value product below 20%.
Oligofructose refers to that 2～5 fructosyls are chain link, the end group with glucosyl group as chain, with fructosyl → really
Sugar connecting key is that main body framework links the carbohydrate formed.I.e. refer to 1～4 fructosyl with β-2,1 is bonded at sucrose
D-Fructose base on and formed ketose (GF2), C24H42 O21 (GF3), Fructofuranosyl nystose (GF4) and sugarcane fruit six sugar (GF5)
Mixture.
Inulin is the mixture of a class natural fruit polysaccharide.Levan be fructose units pass through (2-1) chain attachment form and with
The carbohydrate that glucose unit terminates.Generally in commercialization inulin, the average degree of polymerization (DP) of levan is 10-30.
Pollen Pini is pinaceae plant Pinus massoniana Lamb Pinus massoniana Lamb., Pinus tabulaeformis tabuli formis
Or belong to the dry pollen of several plants together Carr..Spend spring when just opening, pluck spica, dry, collect pollen, remove impurity.
Lentinan is the effective active composition extracted from mushroom fruiting body, and the active component in lentinan is to have
The β of branch-(1-3)-D-glucosan, main chain is made up of the glucosyl group of β-(1-3)-connection, along main chain random distribution by β-
(1-6) glucosyl group connected, in pectinate texture.
Lycopene and astaxanthin belong to antioxidant.
Compound vitamin generally includes Va, Vb1, Vb2, Vb6, Vb12, Vc, Vd, Ve, folic acid, taurine etc..
Composite mineral matter generally includes magnesium, ferrum, calcium, zinc etc..
Wheat essence and sucralose belong to flavoring agent.
Said components all can directly be buied from market.As long as meeting the food standard of national regulation, the present invention is to described group
Divide and have no special requirements.
Powder process of the present invention, can be processed by regular machinery such as such as flour mills.As long as meeting sanitary standard,
The present invention is to milling method and process and has no special requirements.
Optionally, the nutritional support compositions of the present invention or nutritional support meal replacement powder can be carried out sterilization treatment.If it is suitable
Together in the product of the present invention, the present invention is to sterilizing methods and process and has no special requirements, such as, can use ray sterilizing, xeothermic go out
Bacterium, moist heat sterilization etc..Sterilizing does not interferes with the effect of the present invention.
The nutritional support compositions of the present invention and nutritional support meal replacement powder, can add water to reconstitute and eat for atherosclerotic or pasty state
With.The nutrition intake amount recommended according to Chinese Soclety of Nutrition, normal adult human takes 400-500g for one day can meet nutrition need
Want.
Embodiment
For the present invention is better described, it is simple to understand technical scheme, the present invention's is typical but non-limiting
Embodiment is as follows.
One, the composition of embodiment 1-5
Table 1
| Component/content | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 |
| Lactalbumin | 14 weight portions | 15 weight portions | 15 weight portions | 16 weight portions | 18 weight portions |
| Soybean protein isolate | 15 weight portions | 13 weight portions | 12 weight portions | 10 weight portions | 8 weight portions |
| Soybean polypeptide | 1.2 weight portion | 1.5 weight portion | 2 weight portions | 3 weight portions | 4 weight portions |
| Linseed meal | 16 weight portions | 17 weight portions | 18 weight portions | 22 weight portions | 25 weight portions |
| Herba bromi japonici dietary fiber | 25 weight portions | 22 weight portions | 18 weight portions | 17 weight portions | 16 weight portions |
| Maltodextrin | 38 weight portions | 33 weight portions | 28.3 weight portions | 25 weight portions | 23 weight portions |
| Oligofructose | 1.2 weight portion | 1.5 weight portion | 2 weight portions | 3 weight portions | 4 weight portions |
| Inulin | 2 weight portions | 3 weight portions | 5 weight portions | 7 weight portions | 8 weight portions |
| Pollen Pini | 5 weight portions | 3 weight portions | 1 weight portion | 0.7 weight portion | 0.6 weight portion |
| Lentinan | 0.3 weight portion | 0.3 weight portion | 0.5 weight portion | 0.7 weight portion | 0.8 weight portion |
Two, the nutrient of embodiment 1-5
Table 2
Three, the composition of comparative example 1-10
Table 3
Four, the compositions of embodiment 1-5 and comparative example 1-6 is on mouse spleen index and the impact of thymus index
Experimental technique: 60 Kunming mouses (male and female half and half, 8 week old effect, about 25-35g) stochastic averagina is divided into 12 groups, point
Wei be with commercially available conventional Mus grain, the compositions of embodiment 1-5 or the compositions of comparative example 1-6, often every mice feed intake in group
All control in about 5g (dry weight), after feeding 6 weeks, measure spleen index and the thymus index of each group.It is known in the art that spleen index and breast
Gland index is positive relationship with immunity to a certain extent.Result see table.
Table 4
| Group | Spleen index (%) | Thymus index (%) |
| Commercially available Mus grain | 3.89±0.089 | 2.56±0.071 |
| Comparative example 1 | 3.93±0.084 | 2.59±0.069 |
| Comparative example 2 | 3.92±0.075 | 2.57±0.072 |
| Comparative example 3 | 3.95±0.079 | 2.58±0.068 |
| Comparative example 4 | 3.94±0.082 | 2.59±0.065 |
| Comparative example 5 | 3.91±0.086 | 2.60±0.073 |
| Comparative example 6 | 3.90±0.091 | 2.56±0.075 |
| Embodiment 1 | 4.18±0.078 | 2.91+0.071 |
| Embodiment 2 | 4.19±0.065 | 2.90+0.073 |
| Embodiment 3 | 4.26±0.069 | 2.93+0.061 |
| Embodiment 4 | 4.22±0.072 | 2.92+0.065 |
| Embodiment 5 | 4.23±0.081 | 2.92+0.069 |
Note: spleen index=spleen weight/body weight；Thymus index=thymic weight/body weight
From table 4, it can be seen that the compositions of embodiment 1-5 can significantly improve the immunity of mice, and comparative example compositions with
Conventional Mus grain phase comparison immunity has no significant effect, and illustrates that the component of the present composition uses to have together and works in coordination with work
With, thus significantly improve immunity.
Applicant states, the present invention illustrates the method detailed of the present invention by above-described embodiment, but the invention is not limited in
Above-mentioned method detailed, does not i.e. mean that the present invention has to rely on above-mentioned method detailed and could implement.The technology of art
Personnel it will be clearly understood that any improvement in the present invention, the equivalence of raw material each to product of the present invention is replaced and the interpolation of auxiliary element,
Concrete way choice etc., within the scope of all falling within protection scope of the present invention and disclosure.
Claims (10)
1. a nutritional support compositions, it includes following component: the lactalbumin of 10-20 weight %, 5-20 weight % big
Bean separation albumen, the soybean polypeptide of 0.1-5 weight %, the linseed meal of 10-30 weight %, the oat dietary of 10-30 weight %
Fiber, the maltodextrin of 20-40 weight %, the oligofructose of 0.1-5 weight %, the inulin of 0.1-10 weight %, 0.1-10 weight
The amount Pollen Pini of %, the astaxanthin of 0.01-1 weight % and/or lycopene and the lentinan of 0.01-1 weight %.
2. nutritional support compositions as claimed in claim 1, also includes: the compound cellulose of 0.01-1 weight % and 0.01-3
The composite mineral matter of weight %.
3. nutritional support compositions as claimed in claim 1 or 2, also includes: the wheat essence of 0.01-1 weight % and
The sucralose of 0.001-0.5 weight %.
4. a nutritional support compositions, it includes following component: the lactalbumin of 12-18 weight %, 8-15 weight % big
Bean separation albumen, the soybean polypeptide of 1-4 weight %, the linseed meal of 15-25 weight %, the oat dietary fibre of 15-25 weight %
Dimension, the maltodextrin of 22-38 weight %, the oligofructose of 1-4 weight %, the inulin of 2-8 weight %, the pine of 0.5-5 weight %
Pollen, the astaxanthin of 0.1-0.8 weight % and/or lycopene and the lentinan of 0.1-0.8 weight %.
5. nutritional support compositions as claimed in claim 4, also includes: the compound cellulose of 0.02-0.8 weight % and
The composite mineral matter of 0.02-2 weight %.
6. the nutritional support compositions as described in claim 4 or 5, also includes: the wheat essence of 0.1-1 weight % and 0.005-
The sucralose of 0.1 weight %.
7. a nutritional support compositions, it includes following component: the lactalbumin of 13-17 weight %, 10-14 weight % big
Bean separation albumen, the soybean polypeptide of 1.5-3 weight %, the linseed meal of 16-20 weight %, the oat dietary of 16-20 weight %
Fiber, the maltodextrin of 24-32 weight %, the oligofructose of 1.5-3 weight %, the inulin of 3-7 weight %, 0.8-2 weight %
Pollen Pini, the astaxanthin of 0.2-0.7 weight % and/or lycopene and the lentinan of 0.2-0.7 weight %.
8. nutritional support compositions as claimed in claim 7, also includes: the compound cellulose of 0.1-0.7 weight %, 0.5-
The composite mineral matter of 1.8 weight %, the wheat essence of 0.2-0.8 weight % and the sucralose of 0.01-0.08 weight %.
9. a nutritional support meal replacement powder, it is processed by the nutritional support compositions as described in claim 1-8.
10. nutritional support compositions and nutritional support meal replacement powder as claimed in claim 9 as described in claim 1-8 are used for
The purposes of nutritional support.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610098501.7A CN106036815A (en) | 2016-02-23 | 2016-02-23 | Nutritional support composition for rehabilitation of postoperative patient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610098501.7A CN106036815A (en) | 2016-02-23 | 2016-02-23 | Nutritional support composition for rehabilitation of postoperative patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106036815A true CN106036815A (en) | 2016-10-26 |
Family
ID=57484305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610098501.7A Pending CN106036815A (en) | 2016-02-23 | 2016-02-23 | Nutritional support composition for rehabilitation of postoperative patient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106036815A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107510051A (en) * | 2017-10-14 | 2017-12-26 | 云南钰腾生物科技有限公司 | A kind of meal replacement powder of astaxanthin-containing and preparation method thereof |
| CN108902963A (en) * | 2018-05-21 | 2018-11-30 | 李红光 | A kind of brain-tonifying healthcare food |
| CN113100444A (en) * | 2021-05-17 | 2021-07-13 | 天津正大珍吾堂食品股份有限公司 | Enteral nutrition support composition for tumor patients and/or postoperative population and preparation method thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102389111A (en) * | 2011-10-29 | 2012-03-28 | 李南 | Compound edible powder with enhanced effect of preventing and inhibiting cancer |
| CN103431391A (en) * | 2013-08-28 | 2013-12-11 | 张秀平 | Comprehensive nutrition powder |
| CN103478527A (en) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | Low-glycemic-index nutrient powder |
| CN104256595A (en) * | 2014-09-26 | 2015-01-07 | 上海励成营养产品科技股份有限公司 | Intacted protein enteral nutrition multi-polymerization agent |
| CN104366480A (en) * | 2014-11-28 | 2015-02-25 | 哈尔滨墨医生物技术有限公司 | Lipid-lowering and weight-reducing nutritional meal powder and preparation method thereof |
| CN104855957A (en) * | 2015-04-20 | 2015-08-26 | 李燕铭 | Antioxidant and anti-aging medicinal and health-care product |
| CN105077270A (en) * | 2015-07-16 | 2015-11-25 | 上海冬泽特医食品有限公司 | Nutrient supplemented composite powder as well as preparation method and use thereof |
| CN105146368A (en) * | 2015-10-27 | 2015-12-16 | 江西美庐乳业集团有限公司 | Nutritional package for relieving malnutrition and helping after-illness and post-operation physical rehabilitation |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
-
2016
- 2016-02-23 CN CN201610098501.7A patent/CN106036815A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102389111A (en) * | 2011-10-29 | 2012-03-28 | 李南 | Compound edible powder with enhanced effect of preventing and inhibiting cancer |
| CN103478527A (en) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | Low-glycemic-index nutrient powder |
| CN103431391A (en) * | 2013-08-28 | 2013-12-11 | 张秀平 | Comprehensive nutrition powder |
| CN104256595A (en) * | 2014-09-26 | 2015-01-07 | 上海励成营养产品科技股份有限公司 | Intacted protein enteral nutrition multi-polymerization agent |
| CN104366480A (en) * | 2014-11-28 | 2015-02-25 | 哈尔滨墨医生物技术有限公司 | Lipid-lowering and weight-reducing nutritional meal powder and preparation method thereof |
| CN104855957A (en) * | 2015-04-20 | 2015-08-26 | 李燕铭 | Antioxidant and anti-aging medicinal and health-care product |
| CN105077270A (en) * | 2015-07-16 | 2015-11-25 | 上海冬泽特医食品有限公司 | Nutrient supplemented composite powder as well as preparation method and use thereof |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
| CN105146368A (en) * | 2015-10-27 | 2015-12-16 | 江西美庐乳业集团有限公司 | Nutritional package for relieving malnutrition and helping after-illness and post-operation physical rehabilitation |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107510051A (en) * | 2017-10-14 | 2017-12-26 | 云南钰腾生物科技有限公司 | A kind of meal replacement powder of astaxanthin-containing and preparation method thereof |
| CN108902963A (en) * | 2018-05-21 | 2018-11-30 | 李红光 | A kind of brain-tonifying healthcare food |
| CN113100444A (en) * | 2021-05-17 | 2021-07-13 | 天津正大珍吾堂食品股份有限公司 | Enteral nutrition support composition for tumor patients and/or postoperative population and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101606639B (en) | Nursery pig concentrated feed | |
| CN101120747B (en) | Composite material for goose | |
| CN101971928A (en) | Artificial compound feed with function of preventing tilapia mossambica streptococcicosis | |
| CN102984959A (en) | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins | |
| CN106036815A (en) | Nutritional support composition for rehabilitation of postoperative patient | |
| KR101090926B1 (en) | Method for preparing rice milk with high protein content | |
| CN105325732A (en) | Preparation method of nonreactive feed for piglets | |
| CN105454734A (en) | Soybean peptide protein feed used for penaeus vannamei | |
| CN1973662A (en) | Chinese herbal medicine type green concentrated feed for raising fattening pig | |
| KR101405372B1 (en) | Composition for diet containing soybean peptide | |
| US20160295897A1 (en) | Novel non-allergenic snacks containing vegetable proteins | |
| CN103875948A (en) | Formula of compound feed of hybrid broiler silkie | |
| CN106306522A (en) | Meat goose feed and preparation method thereof | |
| CN106173207A (en) | A kind of complex enzyme formula based on feeding guar meal and application thereof | |
| CN102793057A (en) | Compound feed for meat ducklings | |
| CN104472952A (en) | Feed formula for late fattening of mule ducks | |
| CN101019573A (en) | High activity soybean coat dietary fiber milk tablet | |
| WO2020122435A1 (en) | Rice milk employing rice protein and manufacturing method therefor | |
| Zhang et al. | Structural, nutritional, and functional properties of amaranth protein and its application in the food industry: A review | |
| TW201934016A (en) | Hydrolysat proteique de fabacees comme source proteique hypoallergenique dans des compositions alimentaires | |
| CN101703155B (en) | Preparation method and application of prawn non-specific immunity reinforcing agent oligopeptide | |
| CN105286022A (en) | Compound protein powder rich in content of essential amino acids and reasonable in composition and preparation method of compound protein powder | |
| CN103300098A (en) | Natural dietary-nutrition and healthcare serial food | |
| CN114947035A (en) | Probiotic solid beverage using edible fungus superfine powder as prebiotics and preparation method thereof | |
| KR101295633B1 (en) | Manufacturing method of Rice protein plain including high level of Branched chain amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |